Among IDH-mut gliomas the presence of homozygous cyclin-dependent kinase inhibitor 2 A/B (CDKN2A/B) gene deletions of the chromosome 9p21 are associated with significantly poorer prognosis [1, 2, 19, 32, 35, 40]. Here, CDKN2A is linked to central nervous system cancer.